BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
38 results:

  • 1. Clinical Analysis of Pediatric Acute Megakaryocytic leukemia With cbfa2t3-GLIS2 Fusion Gene.
    Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cbfa2t3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
    Gress V; Roussy M; Boulianne L; Bilodeau M; Cardin S; El-Hachem N; Lisi V; Khakipoor B; Rouette A; Farah A; Théret L; Aubert L; Fatima F; Audemard É; Thibault P; Bonneil É; Chagraoui J; Laramée L; Gendron P; Jouan L; Jammali S; Paré B; Simpson SM; Tran TH; Duval M; Teira P; Bittencourt H; Santiago R; Barabé F; Sauvageau G; Smith MA; Hébert J; Roux PP; Gruber TA; Lavallée VP; Wilhelm BT; Cellot S
    Blood Adv; 2024 Jan; 8(1):112-129. PubMed ID: 37729615
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity.
    Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S
    Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic leukemia as Assessed for Causality Using the Updated RUCAM.
    Qin FL; Sang GY; Zou XQ; Cheng DH
    Can J Gastroenterol Hepatol; 2022; 2022():5914593. PubMed ID: 35369115
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lmphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
    Ma RZ; He Y; Yang DL; Wei JL; Pang AM; Jiang EL; Wang JX; Han MZ; Zhang RL; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):383-389. PubMed ID: 34218580
    [No Abstract]    [Full Text] [Related]  

  • 7. Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study.
    Ueno R; Nishimura S; Fujimoto G; Ainiwaer D
    Curr Med Res Opin; 2021 Jul; 37(7):1121-1134. PubMed ID: 33989102
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
    Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Acute Myeloid leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy.
    Conneely SE; Stevens AM
    Curr Oncol Rep; 2021 Jan; 23(2):16. PubMed ID: 33439382
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical Efficacy of ALL-2005 and ALL-2009 Regimen and Factors Influencing Prognosis of Newly Diagnosed ALL Patients Aged between 10-18 Years Old].
    Li X; Si SY; Cai JJ; Qu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1904-1911. PubMed ID: 33283718
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic leukemia.
    Zhang H; Liu AP; Devidas M; Lee SH; Cao X; Pei D; Borowitz M; Wood B; Gastier-Foster JM; Dai Y; Raetz E; Larsen E; Winick N; Bowman WP; Karol S; Yang W; Martin PL; Carroll WL; Pui CH; Mullighan CG; Evans WE; Cheng C; Hunger SP; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2021 Apr; 113(4):408-417. PubMed ID: 32894760
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
    Liao W; Liu Y
    Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Additional gene mutations may refine the 2017 European leukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
    Eisfeld AK; Kohlschmidt J; Mims A; Nicolet D; Walker CJ; Blachly JS; Carroll AJ; Papaioannou D; Kolitz JE; Powell BE; Stone RM; de la Chapelle A; Byrd JC; Mrózek K; Bloomfield CD
    Leukemia; 2020 Dec; 34(12):3215-3227. PubMed ID: 32461631
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiation Exposure During Prostatic Artery Embolisation: A Systematic Review and Calculation of Associated Risks.
    Zumstein V; Binder J; Güsewell S; Betschart P; Pratsinis M; Müllhaupt G; Hechelhammer L; Schmid HP; Abt D
    Eur Urol Focus; 2021 May; 7(3):608-611. PubMed ID: 32418877
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
    Cesini L; Frieri C; Baratè C; Sorà F; Bonifacio M; Cerrano M; Cagnetta A; Elena C; Aprile L; Sgherza N; Trawinska M; Gozzini A; Capodanno I; Crugnola M; Carmosino I; Scalzulli E; Ricci F; Bocchia M; Bergamaschi M; Aguzzi C; Sica S; Galimberti S; Breccia M; Luciano L; Latagliata R
    Eur J Haematol; 2020 Sep; 105(3):286-291. PubMed ID: 32365249
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
    Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
    Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia].
    Shiba N
    Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
    Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
    Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
    Martín I; Navarro B; Villamón E; Solano C; Serrano A; Calabuig M; Amat P; Domingo F; Abellán R; García F; Olivares MD; Chaves FJ; Tormo M; Hernández-Boluda JC
    Exp Mol Pathol; 2018 Aug; 105(1):139-143. PubMed ID: 30017658
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
    Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.